Skip to main content

Advertisement

Table 2 Viral characteristics of the 23 genotypes in vivo and in vitro

From: Viral dominance of reassortants between canine influenza H3N2 and pandemic (2009) H1N1 viruses from a naturally co-infected dog

Genotype Subtype Replicability and pathogenicity
HA titer TCID50/mL EID50/mL MLD50
VC7 H3N2 210 106.6 108.5 n.d.
VC1235678 H3N1 29 105.9 107.25 107.25
VC235678 H3N1 210 105.8 106.5 n.d.
VC78 H3N2 211 106.6 107.5 n.d.
VC123578 H3N2 210 106.8 107.5 104.2
VC678 H3N1 29 106.6 108 n.d.
VC123678 H3N1 210 106.4 107.5 104.9
VC37 H3N2 211 107.8 108 107
VCnone H3N2 210 106.8 106.5 n.d.
VC3578 H3N2 210 106.8 107.5 n.d.
VC12367 H3N1 210 107 107.75 105.5
VC378 H3N2 29 107.5 108 104.25
VC27 H3N2 210 105.8 108 n.d.
VC237 H3N2 210 106.8 107.5 107.26
VC137 H3N2 29 106.8 108.5 n.d.
VC1378 H3N2 29 107.2 108.25 107.75
VC12378 H3N2 210 106.8 107.5 n.d.
VC23578 H3N2 29 106.4 107.25 n.d.
VC125678 H3N1 28 106.2 106.5 104
VC13578 H3N2 29 106.9 107.25 106.85
VC367 H3N1 210 106.6 107.5 n.d.
VC578 H3N2 210 106.6 108.75 n.d.
VC67 H3N1 28 106.9 108.5 n.d.
  1. EID 50 50 % egg infectious dose; HA hemagglutinin; MLD 50 50 % mouse lethal dose; n.d. not determined; TCID 50 50 % tissue culture infectious dose